Safety of Therapeutics Used in Management of Patent Ductus Arteriosus in Preterm Infants

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|10|2|106-112

ISSN： 1574-8863

Source： Current Drug Safety, Vol.10, Iss.2, 2015-07, pp. : 106-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patent Ductus Arteriosus

By  

CONGENITAL HEART DISEASE, Vol. 10, Iss. 1, 2015-01 ,pp. : 86-87

John Wiley & Sons Inc

Access to resources Recommend Favorite

B‐type and N‐terminal pro‐B‐type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants

By  

ACTA PAEDIATRICA, Vol. 104, Iss. 4, 2015-04 ,pp. : e139-e142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transcatheter Closure of Patent Ductus Arteriosus in Under 6 kg and Premature Infants

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 2, 2015-04 ,pp. : 180-189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patent Ductus Arteriosus in Old Age

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 23, Iss. 7, 1975-07 ,pp. : 333-335

John Wiley & Sons Inc

Access to resources Recommend Favorite

PATENT DUCTUS ARTERIOSUS IN OLDER PEOPLE

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 4, 1998-04 ,pp. : 541-542

John Wiley & Sons Inc

Access to resources Recommend Favorite